256 related articles for article (PubMed ID: 27459735)
1. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
[TBL] [Abstract][Full Text] [Related]
3. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer.
Hu CY; Zhang YH; Wang T; Chen L; Gong ZH; Wan YS; Li QJ; Li YS; Zhu B
Clin Exp Immunol; 2016 Oct; 186(1):106-14. PubMed ID: 27447482
[TBL] [Abstract][Full Text] [Related]
5. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW
Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182
[TBL] [Abstract][Full Text] [Related]
6. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
Front Immunol; 2021; 12():760683. PubMed ID: 34966384
[TBL] [Abstract][Full Text] [Related]
7. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.
Ye ZJ; Zhou Q; Yin W; Yuan ML; Yang WB; Xiong XZ; Zhang JC; Shi HZ
Am J Respir Crit Care Med; 2012 Dec; 186(11):1168-79. PubMed ID: 23065014
[TBL] [Abstract][Full Text] [Related]
9. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
[TBL] [Abstract][Full Text] [Related]
10. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
[TBL] [Abstract][Full Text] [Related]
11. Platelet factor 4 regulates T cell effector functions in malignant pleural effusions.
Mulet M; Zamora C; Porcel JM; Nieto JC; Pajares V; Muñoz-Fernandez AM; Calvo N; Esquerda A; Vidal S
Cancer Lett; 2020 Oct; 491():78-86. PubMed ID: 32726613
[TBL] [Abstract][Full Text] [Related]
12. TSAd Plays a Major Role in Myo9b-Mediated Suppression of Malignant Pleural Effusion by Regulating T
Yi FS; Zhang X; Zhai K; Huang ZY; Wu XZ; Wu MT; Shi XY; Pei XB; Dong SF; Wang W; Yang Y; Du J; Luo ZT; Shi HZ
J Immunol; 2020 Nov; 205(10):2926-2935. PubMed ID: 33046503
[TBL] [Abstract][Full Text] [Related]
13. C1q
Zhang S; Peng W; Wang H; Xiang X; Ye L; Wei X; Wang Z; Xue Q; Chen L; Su Y; Zhou Q
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604643
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional characterizations of CD8
Zhang Y; Li W; Zhai J; Jin Y; Zhang L; Chen C
Exp Cell Res; 2022 Aug; 417(1):113212. PubMed ID: 35588796
[TBL] [Abstract][Full Text] [Related]
15. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion.
Huang ZY; Shao MM; Zhang JC; Yi FS; Du J; Zhou Q; Wu FY; Li S; Li W; Huang XZ; Zhai K; Shi HZ
Nat Commun; 2021 Nov; 12(1):6690. PubMed ID: 34795282
[TBL] [Abstract][Full Text] [Related]
16. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
17. The Detection of Immunity against WT1 and SMAD4
Koya T; Niida Y; Togi M; Yoshida K; Sakamoto T; Ura H; Togi S; Kato T; Yamada S; Sugiyama H; Koido S; Shimodaira S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293034
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer.
Maeda J; Ueki N; Ohkawa T; Iwahashi N; Nakano T; Hada T; Higashino K
Clin Exp Immunol; 1994 Nov; 98(2):319-22. PubMed ID: 7955539
[TBL] [Abstract][Full Text] [Related]
19. Chinese medicine Xiaoshui decoction inhibits malignant pleural effusion in mice and mediates tumor-associated macrophage polarization by activating autophagy.
Jin Z; Shen C; Zhang H; Qi R; Guo Q; Liu R; Hua B; Shi Z
J Ethnopharmacol; 2020 Mar; 249():112412. PubMed ID: 31751649
[TBL] [Abstract][Full Text] [Related]
20. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
Guo M; Wu F; Hu G; Chen L; Xu J; Xu P; Wang X; Li Y; Liu S; Zhang S; Huang Q; Fan J; Lv Z; Zhou M; Duan L; Liao T; Yang G; Tang K; Liu B; Liao X; Tao X; Jin Y
Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
